Real-time enrollment status for this refractory multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:47 PM UTC
| NCT Number | NCT05896228 |
| Recruiting Status | Recruiting |
| Condition | Refractory Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Benjamin T Diamond, MD |
| Last Updated on CT.gov | March 11, 2026 (Mar 11, 2026) |
As of July 13, 2026: Clinical trial NCT05896228 is currently recruiting participants. This clinical trial study for refractory multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Benjamin T Diamond, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05896228 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05896228 was last updated Mar 11, 2026 (March 11, 2026). HelloStudys verifies this status automatically.